DARK SECRETS: 2 | Rare Historical Photos

Immunotherapy trial helps cancer patients with tumours live 40% longer

Experts praise groundbreaking results from therapy using genetically modified Car T-cells

The Guardian - UK · May 31, 2025

How a 1970s Chicano art group defied the mainstream and made history

“ASCO: Without Permission” is director Travis Gutiérrez Senger's latest documentary and executive produced by Gael Garcia Bernal and Diego Luna

The Independent UK · Mar 27, 2025

‘Enormous potential’: weight-loss drugs cut cancer risk by a fifth, research shows

Experts believe injections such as Wegovy could play a big role in preventing and treating the disease

The Guardian - UK · Jun 4, 2024

Man rushed to hospital after Peterhead supply base explosion involving chemicals

Emergency services rushed to the Asco facility at Harbourside in the town at around 11am on Wednesday, June 21.

Daily Record · Jun 21, 2023

Explosion rocks supply base in Peterhead sparking emergency response

Workers are said to have been evacuated from the Asco facility at the Harbourside area of the town.

Daily Record · Jun 21, 2023

New trials show increased survival rates for a range of cancers

A roundup of some of the most promising announcements at a meeting of the American Society of Clinical Oncology.

Al Jazeera · Jun 6, 2023

Global ‘silver tsunami’ of older cancer patients is coming, experts warn

Oncologists sound alarm over risk of healthcare systems buckling due to rising need for specific care

The Guardian - UK · Jun 5, 2023

Genetically modifying T-cells cuts blood cancer progression by 74%, trial finds

Therapy slows multiple myeloma in patients who have stopped responding to other treatments, say researchers

The Guardian - UK · Jun 5, 2023

Bowel cancer patients could be spared radiotherapy, US study suggests

Doctors found some patients could rely on chemotherapy and surgery alone to treat the disease

The Guardian - UK · Jun 4, 2023

Breast cancer drug cuts risk of most common form returning by 25%

Trial results presented at US oncology conference suggest ribociclib could be gamechanging and boost survival rate significantly

The Guardian - UK · Jun 2, 2023